학술논문
PP01.01 PEOPLE (NTC03447678), a Phase II Trial to Test Biomarkers of Response to Pembrolizumab as First-Line Treatment in Advanced NSCLC Patients with PD-L1>50%
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology March 2023 18(3) Supplement:e10-e10
Subject
Language
ISSN
1556-0864